EVR GL26_Quality guideline for Fixed Dose Combination Products

EVR GL25_Quality and Equivalence guidelines for topical medicinal products

EVR GL24_Guideline on the quality of oral modified release products

EVR GL23_Guidelines on the pharmaceutical quality of inhalation and nasal products

EVR GL22_Guidelines on the evaluation of biosimilars

EVR GL-10 Rev 0_July 2025 Guideline for drafting and publishing ZIMPARs

EVR GL -11 Rev 0_July 2025 Guideline for drafting and publishing SMPcs

MCAZ-EVR-GL 11 Rev 0_July 2025 Guideline on SMPcs

MCAZ-EVR-GL10 Rev 0_July 2025 Guideline on ZIMPARs

MCAZ/EVR/GL-04 Rev 2_March 2025 Reliance Guidelines for Regulation of Medicines

MCAZ/EVR/GL-01 Rev_3_March 2025 Guideline for Emergency use authorization of medical products

MCAZ-EVR-GL-05 Rev 01_ October 2024 GUIDELINE for permitting the MA not produced in Zimbabwe

MCAZ/EVR/GL-04 – Reliance Guidelines for Regulation of Medicines

SADC GUIDELINE ON PRODUCT INFORMATION LABELLING

Zimbabwe-List-of-COVID-19-Emergency-Use-Authorisations